APO Research
Talk to an analyst

APO RESEARCH · REPORT

Noninfectious Chronic Disease (NCDs) Health Management Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Analysis and Forecast 2026-2032

4 June 2026229 pages

Choose your research edition.

Industry ResearchNoninfectious Chronic Disease (NCDs) Health Management Software Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Noninfectious Chronic Disease (NCDs) Health Management Software Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Noninfectious Chronic Disease (NCDs) Health Management Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Noninfectious Chronic Disease (NCDs) Health Management Software Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Noninfectious Chronic Disease (NCDs) Health Management Software Market Analysis and Forecast 2026-2032229 pages · $4,950 USD

Market perspective

The global Noninfectious Chronic Disease (NCDs) Health Management Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Noninfectious Chronic Disease (NCDs) Health Management Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Noninfectious Chronic Disease (NCDs) Health Management Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Noninfectious Chronic Disease (NCDs) Health Management Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Noninfectious Chronic Disease (NCDs) Health Management Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Noninfectious Chronic Disease (NCDs) Health Management Software include Teladoc Health, Omada Health, Welldoc, Philips Healthcare, Honeywell, Medtronic, Oracle Health, Epic Systems and Athenahealth, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Noninfectious Chronic Disease (NCDs) Health Management Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Noninfectious Chronic Disease (NCDs) Health Management Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Noninfectious Chronic Disease (NCDs) Health Management Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Noninfectious Chronic Disease (NCDs) Health Management Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Noninfectious Chronic Disease (NCDs) Health Management Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Noninfectious Chronic Disease (NCDs) Health Management Software revenue, projected growth trends, production technology, application and end-user industry.

Noninfectious Chronic Disease (NCDs) Health Management Software Segment by Company

Teladoc Health

Omada Health

Welldoc

Philips Healthcare

Honeywell

Medtronic

Oracle Health

Epic Systems

Athenahealth

Veradigm

GE HealthCare

VirtualHealth

Symplr

Conduent

McKesson

Merative

HealthSnap

Huma Therapeutics

ClouDr

WeDoctor

JD Health

Alibaba Health

Ping An Good Doctor

More Health

Winning Health

Neusoft

Welby

CureApp

PHC Holdings

MICIN

Noninfectious Chronic Disease (NCDs) Health Management Software Segment by Type

Basic Integration Type

Multi-source Integration Type

Advanced Integration Type

Others

Noninfectious Chronic Disease (NCDs) Health Management Software Segment by Application

Individual Patient Management

Clinical Practice

Community Health Services

Elderly Care

Corporate Health Management

Health Insurance Management

Medical Research

Others

Noninfectious Chronic Disease (NCDs) Health Management Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Noninfectious Chronic Disease (NCDs) Health Management Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Noninfectious Chronic Disease (NCDs) Health Management Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Noninfectious Chronic Disease (NCDs) Health Management Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Noninfectious Chronic Disease (NCDs) Health Management Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Noninfectious Chronic Disease (NCDs) Health Management Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Noninfectious Chronic Disease (NCDs) Health Management Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Basic Integration Type Major Player Table 3. Multi-source Integration Type Major Player Table 4. Advanced Integration Type Major Player Table 5. Others Major Player Table 6. Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Individual Patient Management Major Player Table 8. Clinical Practice Major Player Table 9. Community Health Services Major Player Table 10. Elderly Care Major Player Table 11. Corporate Health Management Major Player Table 12. Health Insurance Management Major Player Table 13. Medical Research Major Player Table 14. Others Major Player Table 15. Noninfectious Chronic Disease (NCDs) Health Management Software Industry Trends Table 16. Noninfectious Chronic Disease (NCDs) Health Management Software Industry Drivers Table 17. Noninfectious Chronic Disease (NCDs) Health Management Software Industry Opportunities and Challenges Table 18. Noninfectious Chronic Disease (NCDs) Health Management Software Industry Restraints Table 19. Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 20. Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Size by Region (2021-2026) & (US$ Million) Table 21. Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Share by Region (2021-2026) Table 22. Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Size by Region (2027-2032) & (US$ Million) Table 23. Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Share by Region (2027-2032) Table 24. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Players (US$ Million) & (2021-2026) Table 25. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Market Share by Players (2021-2026) Table 26. Global Noninfectious Chronic Disease (NCDs) Health Management Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 27. Global Noninfectious Chronic Disease (NCDs) Health Management Software Key Players Headquarters & Area Served Table 28. Global Noninfectious Chronic Disease (NCDs) Health Management Software Players, Product Type & Application Table 29. Global Noninfectious Chronic Disease (NCDs) Health Management Software Players Establishment Date Table 30. Global Players Market Concentration Ratio (CR5 and HHI) Table 31. Global Noninfectious Chronic Disease (NCDs) Health Management Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Market Share by Type (2021-2026) Table 36. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Market Share by Type (2027-2032) Table 37. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2026) & (US$ Million) Table 39. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2027-2032) & (US$ Million) Table 40. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Market Share by Application (2021-2026) Table 41. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Market Share by Application (2027-2032) Table 42. Teladoc Health Company Information Table 43. Teladoc Health Business Overview Table 44. Teladoc Health Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Teladoc Health Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 46. Teladoc Health Recent Development Table 47. Omada Health Company Information Table 48. Omada Health Business Overview Table 49. Omada Health Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Omada Health Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 51. Omada Health Recent Development Table 52. Welldoc Company Information Table 53. Welldoc Business Overview Table 54. Welldoc Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Welldoc Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 56. Welldoc Recent Development Table 57. Philips Healthcare Company Information Table 58. Philips Healthcare Business Overview Table 59. Philips Healthcare Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Philips Healthcare Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 61. Philips Healthcare Recent Development Table 62. Honeywell Company Information Table 63. Honeywell Business Overview Table 64. Honeywell Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Honeywell Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 66. Honeywell Recent Development Table 67. Medtronic Company Information Table 68. Medtronic Business Overview Table 69. Medtronic Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Medtronic Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 71. Medtronic Recent Development Table 72. Oracle Health Company Information Table 73. Oracle Health Business Overview Table 74. Oracle Health Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Oracle Health Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 76. Oracle Health Recent Development Table 77. Epic Systems Company Information Table 78. Epic Systems Business Overview Table 79. Epic Systems Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Epic Systems Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 81. Epic Systems Recent Development Table 82. Athenahealth Company Information Table 83. Athenahealth Business Overview Table 84. Athenahealth Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Athenahealth Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 86. Athenahealth Recent Development Table 87. Veradigm Company Information Table 88. Veradigm Business Overview Table 89. Veradigm Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Veradigm Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 91. Veradigm Recent Development Table 92. GE HealthCare Company Information Table 93. GE HealthCare Business Overview Table 94. GE HealthCare Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. GE HealthCare Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 96. GE HealthCare Recent Development Table 97. VirtualHealth Company Information Table 98. VirtualHealth Business Overview Table 99. VirtualHealth Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. VirtualHealth Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 101. VirtualHealth Recent Development Table 102. Symplr Company Information Table 103. Symplr Business Overview Table 104. Symplr Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Symplr Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 106. Symplr Recent Development Table 107. Conduent Company Information Table 108. Conduent Business Overview Table 109. Conduent Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Conduent Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 111. Conduent Recent Development Table 112. McKesson Company Information Table 113. McKesson Business Overview Table 114. McKesson Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. McKesson Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 116. McKesson Recent Development Table 117. Merative Company Information Table 118. Merative Business Overview Table 119. Merative Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Merative Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 121. Merative Recent Development Table 122. HealthSnap Company Information Table 123. HealthSnap Business Overview Table 124. HealthSnap Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. HealthSnap Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 126. HealthSnap Recent Development Table 127. Huma Therapeutics Company Information Table 128. Huma Therapeutics Business Overview Table 129. Huma Therapeutics Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Huma Therapeutics Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 131. Huma Therapeutics Recent Development Table 132. ClouDr Company Information Table 133. ClouDr Business Overview Table 134. ClouDr Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. ClouDr Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 136. ClouDr Recent Development Table 137. WeDoctor Company Information Table 138. WeDoctor Business Overview Table 139. WeDoctor Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. WeDoctor Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 141. WeDoctor Recent Development Table 142. JD Health Company Information Table 143. JD Health Business Overview Table 144. JD Health Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. JD Health Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 146. JD Health Recent Development Table 147. Alibaba Health Company Information Table 148. Alibaba Health Business Overview Table 149. Alibaba Health Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Alibaba Health Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 151. Alibaba Health Recent Development Table 152. Ping An Good Doctor Company Information Table 153. Ping An Good Doctor Business Overview Table 154. Ping An Good Doctor Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Ping An Good Doctor Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 156. Ping An Good Doctor Recent Development Table 157. More Health Company Information Table 158. More Health Business Overview Table 159. More Health Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. More Health Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 161. More Health Recent Development Table 162. Winning Health Company Information Table 163. Winning Health Business Overview Table 164. Winning Health Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Winning Health Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 166. Winning Health Recent Development Table 167. Neusoft Company Information Table 168. Neusoft Business Overview Table 169. Neusoft Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. Neusoft Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 171. Neusoft Recent Development Table 172. Welby Company Information Table 173. Welby Business Overview Table 174. Welby Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 175. Welby Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 176. Welby Recent Development Table 177. CureApp Company Information Table 178. CureApp Business Overview Table 179. CureApp Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 180. CureApp Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 181. CureApp Recent Development Table 182. PHC Holdings Company Information Table 183. PHC Holdings Business Overview Table 184. PHC Holdings Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 185. PHC Holdings Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 186. PHC Holdings Recent Development Table 187. MICIN Company Information Table 188. MICIN Business Overview Table 189. MICIN Noninfectious Chronic Disease (NCDs) Health Management Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 190. MICIN Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio Table 191. MICIN Recent Development Table 192. North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2026) & (US$ Million) Table 193. North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2027-2032) & (US$ Million) Table 194. North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2026) & (US$ Million) Table 195. North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2027-2032) & (US$ Million) Table 196. North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2021-2026) & (US$ Million) Table 198. North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (US$ Million) & (2027-2032) Table 199. Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2026) & (US$ Million) Table 200. Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2027-2032) & (US$ Million) Table 201. Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2026) & (US$ Million) Table 202. Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2027-2032) & (US$ Million) Table 203. Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 204. Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2021-2026) & (US$ Million) Table 205. Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (US$ Million) & (2027-2032) Table 206. China Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2026) & (US$ Million) Table 207. China Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2027-2032) & (US$ Million) Table 208. China Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2026) & (US$ Million) Table 209. China Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2027-2032) & (US$ Million) Table 210. Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2026) & (US$ Million) Table 211. Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2027-2032) & (US$ Million) Table 212. Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2026) & (US$ Million) Table 213. Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2027-2032) & (US$ Million) Table 214. Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 215. Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Region (US$ Million) & (2021-2026) Table 216. Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Region (US$ Million) & (2027-2032) Table 217. SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2026) & (US$ Million) Table 218. SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2027-2032) & (US$ Million) Table 219. SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2026) & (US$ Million) Table 220. SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2027-2032) & (US$ Million) Table 221. SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2021-2026) & (US$ Million) Table 223. SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (US$ Million) & (2027-2032) Table 224. Research Programs/Design for This Report Table 225. Authors List of This Report Table 226. Secondary Sources Table 227. Primary Sources List of Figures Figure 1. Noninfectious Chronic Disease (NCDs) Health Management Software Image Figure 2. Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Basic Integration Type Image Figure 5. Multi-source Integration Type Image Figure 6. Advanced Integration Type Image Figure 7. Others Image Figure 8. Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Size Share 2021 VS 2025 VS 2032 Figure 10. Individual Patient Management Image Figure 11. Clinical Practice Image Figure 12. Community Health Services Image Figure 13. Elderly Care Image Figure 14. Corporate Health Management Image Figure 15. Health Insurance Management Image Figure 16. Medical Research Image Figure 17. Others Image Figure 18. Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Size (US$ Million) & (2021-2032) Figure 19. Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global Noninfectious Chronic Disease (NCDs) Health Management Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Market Share by Type (2021-2032) Figure 26. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 28. Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Market Share by Application (2021-2032) Figure 29. North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Type (2021-2032) Figure 31. North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Application (2021-2032) Figure 32. North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Country (2021-2032) Figure 33. United States Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Canada Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Mexico Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 37. Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Type (2021-2032) Figure 38. Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Application (2021-2032) Figure 39. Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Country (2021-2032) Figure 40. Germany Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. France Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. U.K. Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Italy Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Spain Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Russia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Netherlands Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. Nordic Countries Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. China Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. China Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Type (2021-2032) Figure 50. China Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Application (2021-2032) Figure 51. Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 52. Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Type (2021-2032) Figure 53. Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Application (2021-2032) Figure 54. Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Region (2021-2032) Figure 55. Japan Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. South Korea Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. India Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Australia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Taiwan Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Southeast Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 62. SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Type (2021-2032) Figure 63. SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Application (2021-2032) Figure 64. SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Country (2021-2032) Figure 65. Brazil Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Argentina Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Chile Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Colombia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Peru Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Saudi Arabia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Israel Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. UAE Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Turkey Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Iran Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Egypt Noninfectious Chronic Disease (NCDs) Health Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Basic Integration Type
  • Multi-source Integration Type
  • Advanced Integration Type
  • Others
Applications
  • Individual Patient Management
  • Clinical Practice
  • Community Health Services
  • Elderly Care
  • Corporate Health Management
  • Health Insurance Management
  • Medical Research
  • Others
Companies covered
  • Teladoc Health
  • Omada Health
  • Welldoc
  • Philips Healthcare
  • Honeywell
  • Medtronic
  • Oracle Health
  • Epic Systems
  • Athenahealth
  • Veradigm
  • GE HealthCare
  • VirtualHealth
  • Symplr
  • Conduent
  • McKesson
  • Merative
  • HealthSnap
  • Huma Therapeutics
  • ClouDr
  • WeDoctor
  • JD Health
  • Alibaba Health
  • Ping An Good Doctor
  • More Health
  • Winning Health
  • Neusoft
  • Welby
  • CureApp
  • PHC Holdings
  • MICIN

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Noninfectious Chronic Disease (NCDs) Health Management Software Market by Type
  3. 1.2.1 Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Basic Integration Type
  5. 1.2.3 Multi-source Integration Type
  6. 1.2.4 Advanced Integration Type
  7. 1.2.5 Others
  8. 1.3 Noninfectious Chronic Disease (NCDs) Health Management Software Market by Application
  9. 1.3.1 Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Individual Patient Management
  11. 1.3.3 Clinical Practice
  12. 1.3.4 Community Health Services
  13. 1.3.5 Elderly Care
  14. 1.3.6 Corporate Health Management
  15. 1.3.7 Health Insurance Management
  16. 1.3.8 Medical Research
  17. 1.3.9 Others
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Noninfectious Chronic Disease (NCDs) Health Management Software Market Dynamics
  1. 2.1 Noninfectious Chronic Disease (NCDs) Health Management Software Industry Trends
  2. 2.2 Noninfectious Chronic Disease (NCDs) Health Management Software Industry Drivers
  3. 2.3 Noninfectious Chronic Disease (NCDs) Health Management Software Industry Opportunities and Challenges
  4. 2.4 Noninfectious Chronic Disease (NCDs) Health Management Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Perspective (2021-2032)
  2. 3.2 Global Noninfectious Chronic Disease (NCDs) Health Management Software Growth Trends by Region
  3. 3.2.1 Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Noninfectious Chronic Disease (NCDs) Health Management Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Players
  2. 4.1.1 Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Noninfectious Chronic Disease (NCDs) Health Management Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Noninfectious Chronic Disease (NCDs) Health Management Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Noninfectious Chronic Disease (NCDs) Health Management Software Key Players Headquarters & Area Served
  7. 4.4 Global Noninfectious Chronic Disease (NCDs) Health Management Software Players, Product Type & Application
  8. 4.5 Global Noninfectious Chronic Disease (NCDs) Health Management Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Noninfectious Chronic Disease (NCDs) Health Management Software Market CR5 and HHI
  11. 4.6.3 2025 Noninfectious Chronic Disease (NCDs) Health Management Software Tier 1, Tier 2, and Tier 3
5 Noninfectious Chronic Disease (NCDs) Health Management Software Market Size by Type
  1. 5.1 Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2032)
  3. 5.3 Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Market Share by Type (2021-2032)
6 Noninfectious Chronic Disease (NCDs) Health Management Software Market Size by Application
  1. 6.1 Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2032)
  3. 6.3 Global Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Teladoc Health
  2. 7.1.1 Teladoc Health Company Information
  3. 7.1.2 Teladoc Health Business Overview
  4. 7.1.3 Teladoc Health Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Teladoc Health Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  6. 7.1.5 Teladoc Health Recent Developments
  7. 7.2 Omada Health
  8. 7.2.1 Omada Health Company Information
  9. 7.2.2 Omada Health Business Overview
  10. 7.2.3 Omada Health Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Omada Health Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  12. 7.2.5 Omada Health Recent Developments
  13. 7.3 Welldoc
  14. 7.3.1 Welldoc Company Information
  15. 7.3.2 Welldoc Business Overview
  16. 7.3.3 Welldoc Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Welldoc Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  18. 7.3.5 Welldoc Recent Developments
  19. 7.4 Philips Healthcare
  20. 7.4.1 Philips Healthcare Company Information
  21. 7.4.2 Philips Healthcare Business Overview
  22. 7.4.3 Philips Healthcare Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Philips Healthcare Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  24. 7.4.5 Philips Healthcare Recent Developments
  25. 7.5 Honeywell
  26. 7.5.1 Honeywell Company Information
  27. 7.5.2 Honeywell Business Overview
  28. 7.5.3 Honeywell Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Honeywell Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  30. 7.5.5 Honeywell Recent Developments
  31. 7.6 Medtronic
  32. 7.6.1 Medtronic Company Information
  33. 7.6.2 Medtronic Business Overview
  34. 7.6.3 Medtronic Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Medtronic Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  36. 7.6.5 Medtronic Recent Developments
  37. 7.7 Oracle Health
  38. 7.7.1 Oracle Health Company Information
  39. 7.7.2 Oracle Health Business Overview
  40. 7.7.3 Oracle Health Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Oracle Health Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  42. 7.7.5 Oracle Health Recent Developments
  43. 7.8 Epic Systems
  44. 7.8.1 Epic Systems Company Information
  45. 7.8.2 Epic Systems Business Overview
  46. 7.8.3 Epic Systems Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Epic Systems Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  48. 7.8.5 Epic Systems Recent Developments
  49. 7.9 Athenahealth
  50. 7.9.1 Athenahealth Company Information
  51. 7.9.2 Athenahealth Business Overview
  52. 7.9.3 Athenahealth Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Athenahealth Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  54. 7.9.5 Athenahealth Recent Developments
  55. 7.10 Veradigm
  56. 7.10.1 Veradigm Company Information
  57. 7.10.2 Veradigm Business Overview
  58. 7.10.3 Veradigm Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Veradigm Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  60. 7.10.5 Veradigm Recent Developments
  61. 7.11 GE HealthCare
  62. 7.11.1 GE HealthCare Company Information
  63. 7.11.2 GE HealthCare Business Overview
  64. 7.11.3 GE HealthCare Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 GE HealthCare Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  66. 7.11.5 GE HealthCare Recent Developments
  67. 7.12 VirtualHealth
  68. 7.12.1 VirtualHealth Company Information
  69. 7.12.2 VirtualHealth Business Overview
  70. 7.12.3 VirtualHealth Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 VirtualHealth Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  72. 7.12.5 VirtualHealth Recent Developments
  73. 7.13 Symplr
  74. 7.13.1 Symplr Company Information
  75. 7.13.2 Symplr Business Overview
  76. 7.13.3 Symplr Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Symplr Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  78. 7.13.5 Symplr Recent Developments
  79. 7.14 Conduent
  80. 7.14.1 Conduent Company Information
  81. 7.14.2 Conduent Business Overview
  82. 7.14.3 Conduent Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Conduent Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  84. 7.14.5 Conduent Recent Developments
  85. 7.15 McKesson
  86. 7.15.1 McKesson Company Information
  87. 7.15.2 McKesson Business Overview
  88. 7.15.3 McKesson Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  89. 7.15.4 McKesson Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  90. 7.15.5 McKesson Recent Developments
  91. 7.16 Merative
  92. 7.16.1 Merative Company Information
  93. 7.16.2 Merative Business Overview
  94. 7.16.3 Merative Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Merative Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  96. 7.16.5 Merative Recent Developments
  97. 7.17 HealthSnap
  98. 7.17.1 HealthSnap Company Information
  99. 7.17.2 HealthSnap Business Overview
  100. 7.17.3 HealthSnap Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  101. 7.17.4 HealthSnap Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  102. 7.17.5 HealthSnap Recent Developments
  103. 7.18 Huma Therapeutics
  104. 7.18.1 Huma Therapeutics Company Information
  105. 7.18.2 Huma Therapeutics Business Overview
  106. 7.18.3 Huma Therapeutics Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Huma Therapeutics Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  108. 7.18.5 Huma Therapeutics Recent Developments
  109. 7.19 ClouDr
  110. 7.19.1 ClouDr Company Information
  111. 7.19.2 ClouDr Business Overview
  112. 7.19.3 ClouDr Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  113. 7.19.4 ClouDr Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  114. 7.19.5 ClouDr Recent Developments
  115. 7.20 WeDoctor
  116. 7.20.1 WeDoctor Company Information
  117. 7.20.2 WeDoctor Business Overview
  118. 7.20.3 WeDoctor Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  119. 7.20.4 WeDoctor Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  120. 7.20.5 WeDoctor Recent Developments
  121. 7.21 JD Health
  122. 7.21.1 JD Health Company Information
  123. 7.21.2 JD Health Business Overview
  124. 7.21.3 JD Health Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  125. 7.21.4 JD Health Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  126. 7.21.5 JD Health Recent Developments
  127. 7.22 Alibaba Health
  128. 7.22.1 Alibaba Health Company Information
  129. 7.22.2 Alibaba Health Business Overview
  130. 7.22.3 Alibaba Health Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Alibaba Health Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  132. 7.22.5 Alibaba Health Recent Developments
  133. 7.23 Ping An Good Doctor
  134. 7.23.1 Ping An Good Doctor Company Information
  135. 7.23.2 Ping An Good Doctor Business Overview
  136. 7.23.3 Ping An Good Doctor Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Ping An Good Doctor Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  138. 7.23.5 Ping An Good Doctor Recent Developments
  139. 7.24 More Health
  140. 7.24.1 More Health Company Information
  141. 7.24.2 More Health Business Overview
  142. 7.24.3 More Health Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  143. 7.24.4 More Health Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  144. 7.24.5 More Health Recent Developments
  145. 7.25 Winning Health
  146. 7.25.1 Winning Health Company Information
  147. 7.25.2 Winning Health Business Overview
  148. 7.25.3 Winning Health Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  149. 7.25.4 Winning Health Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  150. 7.25.5 Winning Health Recent Developments
  151. 7.26 Neusoft
  152. 7.26.1 Neusoft Company Information
  153. 7.26.2 Neusoft Business Overview
  154. 7.26.3 Neusoft Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  155. 7.26.4 Neusoft Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  156. 7.26.5 Neusoft Recent Developments
  157. 7.27 Welby
  158. 7.27.1 Welby Company Information
  159. 7.27.2 Welby Business Overview
  160. 7.27.3 Welby Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Welby Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  162. 7.27.5 Welby Recent Developments
  163. 7.28 CureApp
  164. 7.28.1 CureApp Company Information
  165. 7.28.2 CureApp Business Overview
  166. 7.28.3 CureApp Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  167. 7.28.4 CureApp Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  168. 7.28.5 CureApp Recent Developments
  169. 7.29 PHC Holdings
  170. 7.29.1 PHC Holdings Company Information
  171. 7.29.2 PHC Holdings Business Overview
  172. 7.29.3 PHC Holdings Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  173. 7.29.4 PHC Holdings Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  174. 7.29.5 PHC Holdings Recent Developments
  175. 7.30 MICIN
  176. 7.30.1 MICIN Company Information
  177. 7.30.2 MICIN Business Overview
  178. 7.30.3 MICIN Noninfectious Chronic Disease (NCDs) Health Management Software Revenue and Gross Margin (2021-2026)
  179. 7.30.4 MICIN Noninfectious Chronic Disease (NCDs) Health Management Software Product Portfolio
  180. 7.30.5 MICIN Recent Developments
8 North America
  1. 8.1 North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue (2021-2032)
  2. 8.2 North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2027-2032)
  5. 8.3 North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2027-2032)
  9. 8.5 North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country
  11. 8.6.1 North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue (2021-2032)
  2. 9.2 Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2027-2032)
  5. 9.3 Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2027-2032)
  9. 9.5 Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country
  11. 9.6.1 Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Noninfectious Chronic Disease (NCDs) Health Management Software Revenue (2021-2032)
  2. 10.2 China Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2032)
  3. 10.2.1 China Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2026)
  4. 10.2.2 China Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2027-2032)
  5. 10.3 China Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Type (2021-2032)
  6. 10.4 China Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2032)
  7. 10.4.1 China Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2026)
  8. 10.4.2 China Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2027-2032)
  9. 10.5 China Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue (2021-2032)
  2. 11.2 Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2027-2032)
  5. 11.3 Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2027-2032)
  9. 11.5 Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country
  11. 11.6.1 Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue (2021-2032)
  2. 12.2 SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country
  11. 12.6.1 SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Noninfectious Chronic Disease (NCDs) Health Management Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst